Journal Club: Slaying the Sleeper Cells of Aging with CAR T
The a16z Show9 Elo 2020

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

CAR T therapy is a groundbreaking medicine that uses engineered T cells to attack cancer. But CAR T cells (that is, chimeric antigen receptor T cells) can be programmed to recognize a huge range of target proteins and cell types. So what other types of cells should we train CAR Ts to recognize and destroy to improve human health?

On this episode of the a16z Journal Club, a16z General Partner Jorge Conde, bio deal team partner Andy Tran, and Lauren Richardson discuss new research published in Nature in which the authors engineer CAR T cells to recognize and kill senescent cells. Cellular senescence is a process where cells stop dividing (sort of go to sleep), and in many cases this can be protective, like its role in tumor suppression, but if too many cells become senescent of if they are not removed, they can trigger inflammation and cause disease, like in atherosclerosis and type 2 diabetes. Critically, senescent cells build up as we age and contribute to a whole host of age-related conditions. In this episode we cover how the authors created these senescence killing (aka senolytic) CAR T cells, the diseases that could be treated with senolytic CAR Ts, the hurdles to getting them into the clinic, and how they could potentially be used to treat aging and possibly improve longevity.

Senolytic CAR T cells reverse senescence-associated pathologies in Nature (June 2020) by Corina Amor, Judith Feucht, Josef Leibold, Yu-Jui Ho, Changyu Zhu, Direna Alonso-Curbelo, Jorge Mansilla-Soto, Jacob A. Boyer, Xiang Li, Theodoros Giavridis, Amanda Kulick, Shauna Houlihan, Ellinor Peerschke, Scott L. Friedman, Vladimir Ponomarev, Alessandra Piersigilli, Michel Sadelain & Scott W. Lowe

a16z bio Journal Club (part of the a16z Podcast), curates and covers recent advances from the scientific literature -- what papers we’re reading, and why they matter from our perspective at the intersection of biology & technology. You can find all these episodes at a16z.com/journalclub.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1000)

Section 230: Everything You Need to Know -- Tweets, Free Speech, Beyond

Section 230: Everything You Need to Know -- Tweets, Free Speech, Beyond

All about section 230 of the Communications Decency Act -- in what Wired senior writer (and host of the Get Wired podcast) described as "one of the clearest-but-still-nuanced explainers I've heard - w...

9 Tammi 202139min

Baumol's Cost Disease, in Healthcare... and Where We Go Next

Baumol's Cost Disease, in Healthcare... and Where We Go Next

If software’s eating the world -- and more specifically, bringing costs down and increasing productivity through entire industries -- why have some industries, like healthcare, been so resistant? And ...

6 Tammi 202130min

Words of 2020! (and Metaphors, and Interfaces of the Year)

Words of 2020! (and Metaphors, and Interfaces of the Year)

"In a year that left us speechless, 2020 has been filled with new words unlike any other”... so it's unprecedented that for the first time, the Oxford English Dictionary did NOT name a word of the yea...

24 Joulu 202051min

The Machine That Made the Vaccine: Company, Platform, Innovation

The Machine That Made the Vaccine: Company, Platform, Innovation

In this special episode of Bio Eats World -- which aired right after the FDA authorized Moderna's mRNA vaccine for emergency use -- Moderna CEO Stephane Bancel tells the story of not just the vaccine’...

21 Joulu 202040min

The PPP Omnibus: Eminent Domain, Fraud, and Fintech

The PPP Omnibus: Eminent Domain, Fraud, and Fintech

This episode features two relevant but previously recorded episodes, discussing the relevance of the Paycheck Protection Program (or PPP) from the Small Business Administration and the role of governm...

14 Joulu 202059min

The Holy Grail of Social + Fintech

The Holy Grail of Social + Fintech

The intersection of social and finance—as well as shifting attitudes around what we share about money online—have given way to an ambitious new wave of financial products.While revealing one’s financi...

7 Joulu 202024min

On Fear and Leadership: Product to Sales CTOs & CEOs

On Fear and Leadership: Product to Sales CTOs & CEOs

There's a few ontologies for describing the phases leaders -- and their startups -- go through, whether it's product-sales-etc. or pioneer to settler. In any case, as companies evolve, so must the lea...

4 Joulu 202042min

On Food As Medicine (A Holiday Snack)

On Food As Medicine (A Holiday Snack)

What happens if we treat food as a medicine in the healthcare system: How, where, and who (pays)? What role can technology play in increasing access, distribution, and more? General partner Julie Yoo ...

26 Marras 202020min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
rss-rahapodi
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahamania
hyva-paha-johtaminen
rss-oivalluksia-rahasta-elamasta
rss-lahtijat
rss-paasipodi
rss-inderes
herrasmieshakkerit
rahapuhetta
oppimisen-psykologia
lakicast
rss-startup-ministerio
rss-bisnesta-bebeja
rss-kaikki-somesta
rss-karon-grilli
rss-set-for-life-sijoita-ja-vaurastu
rss-rentotapaus